Epistasis occurs when the effect of a mutation depends on other mutations in the same sequence. In protein design, mutations that look promising individually may interact unfavorably when combined. section 12.3.5
ESM-2 can help flag potentially problematic combinations using pseudo-perplexity (PPPL), a measure of whole-sequence plausibility. It masks each amino-acid position in turn and scores the actual residue. Lower PPPL means the sequence is more typical of the model’s training distribution; it does not guarantee stability, folding, binding, expression, or biological function. section 12.3.5
Combining antibody mutations
Suppose three mutations in an antibody framework each have positive individual log-likelihood ratios. Compare the PPPL of the variant containing all three with that of the wild type. A higher variant PPPL suggests the combination may create an implausible sequence pattern, warranting more conservative testing. This comparison alone does not prove an epistatic interaction. section 12.3.5

